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Abstract
Objectives: This research investigates the associations between body mass index
(BMI) at 21, 40–59, 60–79 years of age on cardiometabolic risk markers at 60–79
years.
Methods: A prospective study of 3464 British men with BMI measured at 40–59
and 60–79 years, when cardiometabolic risk was assessed. BMI at 21 years was
ascertained from military records, or recalled from middle-age (adjusted for
reporting bias); associations between BMI at different ages and later
cardiometabolic risk markers were examined using linear regression. Sensitive
period, accumulation and mobility life course models were devised for high BMI
(defined as BMI>75th centile) and compared with a saturated BMI trajectory model.
Results: At ages 21, 40–59 and 60–79 years, prevalences of overweight
(BMI>25 kg/m2) were 12%, 53%, 70%, and obesity (>30 kg/m2) 1.6%, 6.6%, and
17.6%, respectively. BMI at 21 years was positively associated with serum insulin,
blood glucose, and HbA1c at 60–79 years, with increases of 1.5% (95%CI
0.8,2.3%), 0.4% (0.1,0.6%), 0.3% (0.1,0.4%) per 1 kg/m2, respectively, but showed
no associations with blood pressure or blood cholesterol. However, these
associations were modest compared to those between BMI at 60–79 years and
serum insulin, blood glucose and HbA1c at 60–79 years, with increases of 8.6%
(8.0,9.2%), 0.7% (0.5,0.9%), and 0.5% (0.4,0.7%) per 1 kg/m2, respectively. BMI at
60–79 years was also associated with total cholesterol and blood pressure.
Associations for BMI at 40–59 years were mainly consistent with those of BMI at
60–79 years. None of the life course models fitted the data as well as the saturated
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model for serum insulin. A sensitive period at 50 years for glucose and HbA1c and
sensitive period at 70 years for blood pressure were identified.
Conclusions: In this cohort of men who were thin compared to more contemporary
cohorts, BMI in later life was the dominant influence on cardiovascular and diabetes
risk. BMI in early adult life may have a small long-term effect on diabetes risk.
Introduction
Adult overweight and obesity are leading global risk factors for mortality and
disability, particularly in middle and high income countries.[1] Prevalences of
overweight and obesity in middle-aged and older adults have increased markedly
across the world in recent decades;[2–4] and are strongly associated with major
chronic diseases, including cardiovascular disease and type 2 diabetes.[5–8]
However, there is growing concern about the emergence of overweight and
obesity earlier in the life course, during early adult life, adolescence and in
childhood. The early development of adiposity has immediate adverse effects on
established cardiovascular risk factors [9] and diabetic precursors,[10, 11] which
may persist,[12] as well as strongly predisposing to overweight and obesity in
middle-age.[13, 14] It is possible that higher levels of adiposity for increasing
duration may have serious additional adverse long-term health consequences,
particularly for cardiovascular disease and type 2 diabetes in middle and later
life.[15, 16] However, its effects have not been fully elucidated.
Further elucidation of the impact of adiposity in early adult life on
cardiovascular disease and diabetes requires data from long-term cohort studies
with accurate information on adiposity in early adult life, middle-age and later
adult life as well as long-term prospective data on cardiovascular and diabetes
risk.[16, 17] Few prospective studies (either birth cohort studies or conventional
cohorts from adult life) have data of this kind.[5, 16, 18–20] We have obtained
data from military service records on measured weight and height in early adult
life for participants in an established cohort of British men examined at 40–59 and
60–79 years in order to study the impact of adiposity in early, middle and later
adult life on cardiometabolic risk at 60–79 years. Throughout this report body
mass index (BMI) in early adult (mean age 21 years), middle-age (mean age 50
years) and late adulthood (mean age 70 years) are referred to as BMI-21, BMI-50
and BMI-70 respectively.
Methods
The British Regional Heart Study (BRHS) is a long-term prospective study of risk
factors for cardiovascular disease and type 2 diabetes among middle-aged and
older British men. It is based on 7735 men (78% response) born between 1919
and 1939 who were recruited in 1978–80 aged 40–59 years from a single General
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Practice in each of 24 British towns.[21] The BRHS was a predominantly white
European cohort of men (.99% white European). Ethical approval for the BRHS
including the investigation of military records reported here has been provided by
the London Multicentre Research Ethics Committee and its successor, the
Research Ethics Committee for London Central (approval reference MREC/02/02/
91). Study participants had a detailed examination and questionnaire assessment
at entry and completed periodic postal questionnaires about their health in 1983–
5, 1992 and 1996; in 1996 they were asked to recall their weight at age 21 years. In
1998–2000, all surviving men (n55516) were invited for a detailed 20 year follow-
up examination aged 60–79 years, of whom 4252 men (77%) attended for re-
examination. In 2007, a questionnaire was sent to all surviving men enquiring
about military service in early adulthood, either during World War II (1939–
1945) or during National Service (1945–1963), including details of service period
and service number where available. Participants were asked for written
permission to allow the researchers to obtain relevant health information from the
military records.
Baseline and 20 year assessment
At both assessments, men provided information on medical history, use of regular
medications and lifestyle behaviour (including smoking status, physical activity,
alcohol intake and social class). Standing height and weight were measured with
participants in light clothing without shoes; height was measured to the last
complete 0.1 cm using a Harpenden stadiometer, and weight to the last 0.1 kg
using regularly calibrated scales. At the 20 year assessment two resting
measurements of seated blood pressure were measured in the right arm using an
automated blood pressure monitor (Dinamap 1846, Critikon Corporation,
Tampa, FL, USA) with an appropriately sized cuff; values were adjusted for
overreading of systolic blood pressure by the instrument [22] and for observer
variation.[23] A fasting venous blood sample was collected from all participating
men. Details of analytic methods have been previously documented.[24] HbA1c
was measured in whole blood using high performance liquid chromatography.
Serum total cholesterol and HDL-cholesterol were measured using an auto-
analyser (Hitachi 747, Hitachi, Tokyo, Japan). LDL-cholesterol was calculated
using the Friedrickson–Friedwald equation.[25] Plasma glucose was measured
using a glucose oxidase method; serum insulin was measured using an ELISA
method that does not cross-react with proinsulin.[26] All cardiovascular risk
factors and metabolic markers were adjusted for time of day, and fasting
duration.[24].
Weight and height during military service
With ethical committee approval, military records were sought for all study
participants (including deceased participants) except those who refused consent
or confirmed that they had not undertaken military service. All information
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obtained from military records was de-identified prior to analysis, being linked
only on the basis of the unique study identifier. Military service records
(electronically indexed by name, date or birth, and service number) were retrieved
from the single UK repository (TNT Ltd, Swadlincote, Derbyshire) and reviewed
by a trained researcher. All measures of weight and height recorded at entry to the
armed services and at other times during service were recorded
Data management and statistical methods
Weight at 21 was obtained using armed service records or, where not available,
from self-reported weight at age 21 recalled in 1996. For armed service records,
weight recorded between 20 and 22 years, using the value recorded closest to 21
years, was used as a measurement of weight at 21 years without adjustments.
Where measurements between 17–19 or 23–25 years (but not 20–22 years) were
available, weight at 21 years was estimated from a multi-level model fitted using
all weight measurements recorded between 17 and 25 years of all individual
participants, adjusting for age (allowing for a quadratic relationship) and period
of enlistment (1934–38, 1939–45, 1946–50, 1951–55, 1956–75). The model
included a random intercept and random slope for the linear term of age to take
account of clustering of measures within individual. When recalled weight in 1996
was used, this was adjusted for recall bias quantified by comparisons of measured
(within the age range 20–22 years and closest to age 21) and recalled weight at 21
years in 694 individuals with data from both sources. Recall was associated with a
small overestimation of weight at 21 years in men who were thinner than average
(mean estimated bias across the range of measured weight was 1.5 kg with a
maximum of 6.9 kg estimated at the lowest limit of the range of measured weight)
(Figure S1 in File S1). Height measurements recorded in military records were
used to provide an estimate of height at 21 years using similar methods as for
weight. Shrinkage between 21 years and measured height at mean 50 years (was
0.2 cm; 95%CI 0 cm to 0.3 cm) was modelled using data from 1248 individuals
with height from both sources. Body mass index (BMI) at mean 21, 50 and 70
years was calculated as weight/height squared in kg/m2.
Statistical methods
Physical and metabolic factors were summarised by quintiles of BMI-21 to
examine patterns of association. Linear regression was used to assess the
associations between BMI-21, BMI-50, and BMI-70 and cardiovascular and
metabolic risk markers in late adulthood (adjusting for age at outcome and town
as a fixed effect); percentage changes were examined for log transformed markers.
The associations between BMI-70 and cardiometabolic markers were stratified by
quintiles of BMI-21 to examine effect modification using a test for trend obtained
from meta-regression. Patterns of high BMI over the life course were defined
according to whether an individual was below (0) or on/above (1) the 75th
percentile of the BMI distribution at each age period (early, middle, later adult
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life) and were denoted by a triplet of zeros and ones (8 trajectories in all). The
regression coefficients for all trajectories were used to examine life course
patterning of cardiometabolic risk, adjusting for age at outcome and town
(saturated model). Other life course models including sensitive period,
accumulation and exposure change models [27] were also investigated. Sensitive
period models assume that cardiometabolic risk markers may depend on some or
all the periods in which participants have had high BMI, but having high BMI
during a particular age period is associated with a greater effect.[27] Under the
hypothesis of accumulation, having high BMI has a cumulative effect to
cardiovascular risk markers in late adulthood irrespectively of the time one has
had high BMI.[27] The assumption behind an exposure change model is that any
upward change in BMI classification (from no high BMI to high BMI), and any
downward change in BMI classification (from high BMI to no high BMI) have
equal effect irrespectively of the age period that this change has happened (from
early to middle adulthood, or from middle to late adulthood). These models are
special cases of the saturated model that includes all 8 trajectories of high BMI
over the life course. The saturated model was compared with the simpler models
using likelihood ratio tests to examine whether the simpler model fitted the data
equally well.[27].
Results
Among 4252 men who attended for examination at both mean 50 and 70 years
(78% and 77% response rate among survivors respectively), information on
weight at 21 years was available for 3464 (82%) men. Among these, 1252 men had
data available from military records and 2906 men had participant recall from the
1996 questionnaire; 694 men had data from both sources.
Table 1 presents the cohort characteristics at mean age 21, 50 and 70 years by
quintile of BMI-21 in all men. Mean BMI rose between early, middle and late
adulthood, whereas height was reduced marginally between age 21 and 50 years,
with a small shrinkage (1.5 cm, p,0.001) between mean age 50 and 70 years.
Figure 1 illustrates the distribution of BMI-21, BMI-50 and BMI-70. Both
prevalences of overweight (defined as BMI >25 kg/m2) and obesity (defined as
BMI >30 kg/m2) rose steeply with increasing age (12%, 53%, 70%; 1.6%, 6.6%,
17.6% respectively). A comparison of BMI-21, BMI-50 and BMI-70 between
individuals with available data at all age periods and those excluded from our
analyses because of missing values in at least one age period showed small
differences between the two groups at mean age 21 and 50 years (difference
20.18 kg/m2, p50.04; 0.17 kg/m2, p50.019; respectively), and little difference in
BMI-70 (-0.07 kg/m2, p50.62). Figure 2 shows the trajectory of early BMI
quintiles into middle-age and later life. The absolute and relative rates of increase
in average BMI between early and middle-age were highest for those in the lowest
quintile of BMI-21 and lowest for those in the highest quintile. While trajectories
of average BMI did not cross over the life course, only 18% of men remained in
Effect of Life Course Adiposity in Late Adult Life
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Table 1. Cohort characteristics in early, middle, and late adulthood in all men, and by quintile of BMI in early adulthood.
Characteristic Percentile group of BMI at age 21 years
All 0%–20% 21%–40% 41%–60% 61%–80% 81%–100%
n Mean ¡ SD/% n Mean ¡ SD n Mean ¡ SD n Mean ¡ SD n Mean ¡ SD n Mean ¡ SD
Measurements at mean age
21 years (early adulthood)
BMI (kg/m2) 3464 22.0¡3.0 703 18.4¡1.4 671 20.5¡0.4 680 21.7¡0.3 671 22.9¡0.4 739 26.1¡2.6
normal-weight
(BMI,25 kg/m2) 3043 87.9%
overweight (25 kg/m2#
BMI,30 kg/m2) 367 10.6%
obese (BMI>30 kg/m2) 54 1.6%
Weight (kg) 3464 66.8¡10.4 703 55.8¡6.0 671 62.3¡4.2 680 65.7¡4.4 671 69.6¡5.1 739 79.7¡10.1
Height (m) 3464 1.74¡0.06 703 1.74¡0.06 671 1.74¡0.06 680 1.74¡0.06 671 1.74¡0.06 739 1.75¡0.06
Measurements at mean age
50 years (middle-age)
Age (years) 3464 48.8¡5.5 703 49.6¡5.7 671 49.0¡5.3 680 48.8¡5.4 671 48.3¡5.3 739 48.2¡5.5
BMI (kg/m2) 3464 25.4¡3.0 703 23.7¡2.9 671 24.4¡2.5 680 25.1¡2.4 671 25.9¡2.5 739 27.6¡3.0
normal-weight
(BMI,25 kg/m2) 1628 47.0%
overweight (25 kg/m2#
BMI,30 kg/m2) 1606 46.4%
obese (BMI>30 kg/m2) 230 6.6%
Weight (kg) 3464 77.0¡10.3 703 71.8¡9.7 671 73.9¡8.7 680 75.9¡8.6 671 78.5¡9.1 739 84.2¡10.4
Height (m) 3464 1.74¡0.06 703 1.74¡0.07 671 1.74¡0.06 680 1.74¡0.06 671 1.74¡0.07 739 1.74¡0.07
Measurements at mean age
70 years (late
adulthood)
Age (years) 3464 68.6¡5.5 703 69.4¡5.7 671 68.7¡5.3 680 68.6¡5.4 671 68.1¡5.3 739 68.0¡5.5
BMI (kg/m2) 3464 27.0¡3.7 703 25.3¡3.6 671 26.1¡3.3 680 26.5¡3.2 671 27.4¡3.2 739 29.3¡3.9
normal-weight
(BMI,25 kg/m2) 1054 30.4%
overweight (25 kg/m2#
BMI,30 kg/m2) 1799 51.9%
obese (BMI>30 kg/m2) 611 17.6%
Weight (kg) 3464 80.3¡12.5 703 74.9¡11.6 671 77.5¡11.0 680 78.8¡10.9 671 81.8¡11.5 739 87.9¡13.1
Height (m) 3464 1.72¡0.06 703 1.72¡0.07 671 1.72¡0.06 680 1.72¡0.06 671 1.73¡0.07 739 1.73¡0.06
Total cholesterol (mmol/L) 3287 6.0¡1.1 663 6.0¡1.1 635 6.1¡1.1 642 6.0¡1.0 642 6.0¡1.1 705 6.0¡1.1
LDL cholesterol (mmol/L) 3244 3.9¡1.0 654 3.8¡1.0 627 4.0¡1.0 631 3.9¡0.9 637 3.9¡1.0 695 3.9¡1.0
SBP (mmHg) 3450 148.8¡24.2 702 148.6¡25.1 667 149.1¡24.2 679 148.4¡24.1 665 148.8¡23.6 737 148.8¡24.2
DBP (mmHg) 3450 85.1¡11.1 702 84.6¡11.6 667 84.8¡10.8 679 84.6¡11.1 665 85.9¡11.0 737 85.4¡11.1
Insulin (mIU/mL)a 3280 8.7 (5.7, 12.4) 666 8.6 (5.5, 12.6) 632 8.5 (5.6, 12.3) 642 8.3 (5.5, 11.8) 641 8.3 (5.6, 11.6) 699 9.6 (6.4, 13.7)
Glucose (mmol/L)a 3287 5.8 (5.2, 6.1) 664 5.8 (5.3, 6.0) 636 5.8 (5.2, 6.1) 641 5.8 (5.2, 6.1) 643 5.8 (5.2, 6.0) 703 5.9 (5.2, 6.2)
HbA1c (%) 3287 5.0¡0.9 666 5.0¡0.9 635 5.0¡0.8 642 5.0¡0.8 643 5.0¡0.9 701 5.1¡1.0
HbA1c (mmol/mol) 3280 31.3¡9.8 665 31.4¡9.5 634 30.8¡9.0 641 30.8¡9.0 641 31.3¡10.2 699 32.3¡11.0
n: Number of participants (subset of individuals with BMI available at all age periods).
SD: Standard deviation.
a: Estimates correspond to geometric mean (Q1, Q3).
Quintiles of BMI at 21 years are calculated using all available data (including individuals with missing BMI at mean age 50 or 70 years).
doi:10.1371/journal.pone.0114289.t001
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Figure 1. Distribution of BMI at mean age 21 years (early adulthood), 50 years (middle-age), and 70
years (late adulthood).
doi:10.1371/journal.pone.0114289.g001
Figure 2. Mean BMI at mean age 21, 50 and 70 years, stratified by quintile of BMI distribution at age 21
(quintiles formed by using all available data at age 21; lines from bottom to top correspond to 1st, 2nd,
3rd, 4th, and 5th quintiles, respectively). Note: Individuals may be moving across quintiles.
doi:10.1371/journal.pone.0114289.g002
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the same quintile of BMI distribution at all age periods. For example, treating
individuals in each quintile of BMI at mean age 21 years as five separate groups,
those in the bottom quintile had the lowest average BMI at both mean age 50 and
70 years. However, only 40% and 38% of individuals in the bottom quintile of
BMI at mean age 21 years were amongst those in the lowest BMI quintile at mean
age 50 and at mean age 70 years, respectively.
Table 2 shows the difference in cardiovascular and metabolic risk markers at 70
years of age, associated with a 1 kg/m2 higher BMI at each different age-group
(BMI-21, BMI-50, BMI-70) separately. BMI at all age periods was significantly
associated with insulin, glucose and HbA1c. However, these associations were
weaker for BMI-21 than for BMI-50 and BMI-70 (regression coefficients for BMI-
21 were a fifth for serum insulin, and between a half to a third for blood glucose
and HbA1c, of those for BMI-50 and BMI-70). BMI-50 and BMI-70 showed
positive associations with systolic and diastolic blood pressure, while BMI-21
showed no association. LDL-cholesterol showed no association with BMI at any
age; total cholesterol was only associated with BMI-70. There was no evidence to
suggest that the associations between BMI-70 and any risk marker were modified
by the level of BMI-21 (i.e., there was no interaction between BMI-70 and
quintiles of BMI-21 - Table S1 in File S1).
Table 3 shows the difference in cardiovascular and diabetes risk markers at 70
years of age associated with having high BMI (a BMI on or above the 75th centile)
separately at mean age 21, 50 and 70 years, when compared to men who never had
high BMI (separate analyses based on sensitive period models). Having high BMI
at any one of these three ages was associated with raised levels of insulin, glucose,
HbA1c and diastolic blood pressure at mean age 70 years, though the differences
were greater for high BMI-50 and BMI-70 than for BMI-21. Additionally, the
presence of a high BMI at mean age 50 and 70 years was associated with higher
Table 2. Differences in cardiovascular and diabetes risk markers at mean age 70 years for each 1 kg/m2 increase in BMI separately at mean age 21, 50 and
70 years.
Outcome (mean age 70
years) BMI at mean age 21 years BMI at mean age 50 years BMI at mean age 70 years
n Coef (95% CI)
p-
value n Coef (95% CI)
p-
value n Coef (95% CI)
p-
value
Total cholesterol (mmol/L) 3287 –0.009 (–0.022, 0.003) 0.15 3287 –0.007 (–0.020, 0.005) 0.260 3287 0.011 (0.001, 0.021) 0.03
LDL cholesterol (mmol/L) 3244 –0.007 (–0.018, 0.005) 0.25 3244 –0.009 (–0.020, 0.0022) 0.115 3244 0.005 (–0.005, 0.014) 0.32
SBP (mmHg) 3450 0.123 (–0.149, 0.395) 0.37 3450 0.492 (0.223, 0.761) ,0.001 3450 0.696 (0.481, 0.910) ,0.001
DBP (mmHg) 3450 0.083 (–0.043, 0.210) 0.20 3450 0.192 (0.067, 0.318) 0.003 3450 0.336 (0.236, 0.436) ,0.001
Insulin (% difference) 3280 1.525 (0.771, 2.285) ,0.001 3280 7.614 (6.862, 8.371) ,0.001 3280 8.587 (8.014, 9.164) ,0.001
Glucose (% difference) 3287 0.362 (0.127, 0.598) 0.003 3287 1.096 (0.863, 1.330) ,0.001 3287 0.733 (0.545, 0.922) ,0.001
HbA1c (%) 3287 0.016 (0.006, 0.026) 0.002 3287 0.046 (0.036, 0.056) ,0.001 3287 0.030 (0.022, 0.038) ,0.001
HbA1c (mmol/mol) 3280 0.177 (0.067, 0.288) 0.002 3280 0.488 (0.380, 0.597) ,0.001 3280 0.322 (0.234, 0.410) ,0.001
n: Number of participants (subset of individuals with BMI available at all age periods).
Coef: regression coefficient represent difference in cardiovascular risk markers for 1 kg/m2 increase in BMI. Estimates are adjusted for age at the time when
the risk markers were measured, and town as a fixed effect.
doi:10.1371/journal.pone.0114289.t002
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systolic pressure at mean age 70 years. Over 40% of individuals with high BMI at
mean age 21 and over 70% of individuals with high BMI at mean age 50 years also
had high BMI at mean age 70 years. Hence, the effects of high BMI at different
periods were not independent.
Table 4 shows the differences in cardiovascular and diabetes risk markers at 70
years of age associated with each life course BMI trajectory (having a high BMI at
different points of the life course), expressed as the difference in risk markers from
the reference (0–0–0) trajectory (i.e., where high BMI was not present at any age).
The strongest effects were apparent for insulin. Having a high BMI in at least one
age period, when compared to normal BMI at all ages, was associated with higher
insulin levels at mean age 70 years, with the exception of those with high BMI only
at age 21 years. High BMI-70 was associated with the highest levels of insulin.
Glucose and HbA1c were both higher when BMI-50 was higher; HbA1c alone was
increased when BMI-70 was increased. Men with both high BMI-50 and BMI-70
showed higher levels of systolic and diastolic blood pressure when compared to
men who never had high BMI; men with high BMI-70 only also had higher
systolic blood pressure. Men with a high BMI at age 21 years and normal BMI at
50 and/or 70 years tended to have similar blood pressures at 70 years to men who
had never had high BMI. There was an exception to this pattern; men with high
BMI at 21 and 70 years but not at age 50 years had increased levels of diastolic
blood pressure when compared with those who never had high BMI. Total and
LDL cholesterol levels were not appreciably associated with BMI at any age.
Compared with the saturated model (8 BMI trajectories presented in table 4)
the likelihood ratio tests (LRT) suggested a sensitive period to high BMI-50 years
for glucose and HbA1c at 70 years (LRT p50.49 and p50.16 respectively) and a
sensitive period to high BMI-70 years for blood pressure at 70 years (LRT p50.86
for systolic blood pressure and p50.69 for diastolic blood pressure). For insulin
however, none of the other life course models (sensitive period, accumulation or
mobility) fitted the data as well as the saturated model.
Additional adjustment for smoking in all models made little difference to the
results. The exclusion of participants on lipid lowering medication, blood pressure
lowering medication or blood glucose lowering medication did not affect the
results presented in Tables 2–4 for total and LDL cholesterol, blood pressure and
glucose, insulin, HbA1c respectively (data not presented).
Discussion
Although adiposity in middle-age is an established risk factor for cardiovascular
disease and type 2 diabetes,[5–8] the impact of high BMI from early adult life on
these outcomes is not clearly established. Birth cohort studies often have
information on adiposity both before and during middle-age,[18–20] but
generally have populations which are too young to have large numbers of chronic
disease events in later life. Many prospective studies have data on adiposity in
middle-age and its relation to subsequent chronic disease outcomes [5, 28] but
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few of these also have information on adiposity in early adult life.[16] This study
provides novel information on the association between high BMI at different
points of the life course and cardiovascular and metabolic risk factors in later life.
Findings are based on a large white European male cohort born in the early 20th
century, who were thin compared to more contemporary cohorts. While early
BMI had little influence on cardiovascular risk factors, it was associated with
metabolic factors related to type 2 diabetes risk, suggesting some early patterning
of diabetes risk. This may have greater relevance to more recent cohorts with
higher levels of BMI from an early age.
Previous studies
Our observation that BMI in later life was a considerably more important
determinant of both cardiovascular and metabolic risk than BMI in early life is in
agreement with an overwhelming body of evidence showing that adiposity and
weight gain in middle-age show strong, graded associations with cardiovascular
disease, type 2 diabetes and their precursors in later life.[5–8, 15] In the present
study, early BMI had a modest association with metabolic markers related to
diabetes risk, though not with cardiovascular risk factors. Further support of an
association between early life BMI and diabetes risk is evident from our life course
approach; for serum insulin none simpler model (sensitive period, mobility or
accumulation models) fitted the data as well as the saturated model. This is
consistent with the results of recent studies which have suggested that adiposity in
early adult life is strongly related to the early development of T2D,[10, 29] and
that a greater duration of adiposity may have an important impact on T2D
risk.[11] This is also coherent with the observation in Israeli army recruits that
high BMI in adolescence was related to type 2 diabetes in later life; in that study
the association was abolished after adjustment for adult BMI.[30] That study also
reported that weight loss in early adult life among overweight adolescents may be
associated with lower diabetes risk.[30] In the present study, high BMI in early
adult life followed by normal BMI in middle and later life was associated with
similar or marginally lower insulin and glucose levels in later life, again suggesting
that the effects of high BMI in early life may be reversible by subsequent weight
loss.
The present study found no evidence that early BMI related to blood pressure
and blood cholesterol levels. Previous analyses examining the associations of BMI
at different ages on blood pressure and blood cholesterol at 45 years in the 1958
British birth cohort (NCDS)[12, 31] were consistent with the present study in
observing that current BMI had much stronger associations than earlier BMI with
blood pressure and non-HDL cholesterol. However, in contrast with our findings,
BMI at 23 years showed weak positive associations with both blood pressure and
non-HDL cholesterol at 45 years. In the 1958 British birth cohort, the associations
between current BMI and both blood pressure and non-HDL cholesterol were
modified by earlier BMI, being particularly strong in individuals who were thinner
at younger ages; we were unable to confirm these findings in the BRHS. Both the
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present study and the 1958 British birth cohort were however consistent in
showing that recent weight gain was most strongly associated with blood pressure
level in middle or later life;[12] in the 1958 British birth cohort but not in the
present study, similar associations were observed for non-HDL cholesterol.[31]
Taken together, the limited evidence relating early adult BMI to later
cardiovascular risk in the present study is consistent with the conclusions of a
recent review.[32].
Strengths and limitations
The investigation is based on a geographically and socially representative cohort
study with high response rates and exceptionally high follow-up rates. This study
has used a novel approach in extending an established cohort of middle aged men
by using data on BMI from military service records as a source of information in
early adulthood. Among men who survived to the 60–79 year re-examination, it
was possible using the combination of two sources of information, military health
records and participant recall, to obtain information on BMI at 21 years for a high
proportion of participants (82%); information from military records was
documented at the time of measurement and recalled data were substantially
consistent. The availability of data from both sources in 694 men allowed
adjustment for a small bias in recalled weight and validated the use of recalled
weight. Although the analyses were based on slightly fewer than half of
participants in the original cohort, inevitably being based on a healthy survivor
group, baseline risk factor differences in men who were or were not included in
the present analyses did not differ markedly (data not presented). Hence,
underestimation of potential associations between early BMI and later
cardiometabolic risk because of earlier mortality amongst participants at greatest
risk is likely to be limited. A further concern is the extended time interval between
BMI at 21 years and cardiometabolic outcomes about 50 years later, by which
point the development of disease could make the detection of associations
difficult. However, the results for blood lipids, blood pressure and insulin and
glycaemia markers were not materially affected by exclusion of study participants
receiving medications likely to have affected these outcome measures. BMI is only
one of many surrogate markers of adiposity. Unfortunately, other measures of
adiposity such as waist circumference, waist to hip ratio and percentage of fat
mass were only available for the 60–79 year examination and their use would have
undermined a key strength of the current analysis, that the same marker of
adiposity was used for all age groups. Moreover, BMI is highly correlated with fat
mass both in this population (at 70 years, r50.70, p,0.001). Although BMI is a
robust measure of overall adiposity, its association with body fatness differs with
age; in later life changes in muscle mass as well as fatness are important influences
on BMI.[33] Reassuringly, the exclusion of men aged 75 years and over (in whom
loss of muscle mass is likely to influence BMI [34]) made little difference to the
findings. However, other direct measures of adiposity (including central
adiposity) could help to explain why associations between adiposity and
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cardiovascular risk markers were limited in strength or absent. In addition, the
limited number of study participants with high levels of adiposity in early life
limits the ability of the investigation to detect the effects of adiposity at this stage
of the life course. The analytic strategies used in this report focus on the
comparative strength and consistency of independent associations between
adiposity at each age time point (in early adulthood, middle-age, and later life)
and cardio-metabolic risk in later life, corresponding with models used in other
relevant recent reports.[12, 35, 36] We have avoided models using mutual
adjustment for BMI at different stages of the life course, which have been shown
to yield confusing or erroneous estimates of associations [37, 38] (Statistical
appendix S1 in File S1). Moreover, we have assessed how different life course
patterns and potentially cumulative or combined associations between BMI at
different stages of the life course are associated with cardio-metabolic risk,
comparing the presence of high BMI at three, two, one and no stages of the life
course.
Implications
The results suggest that BMI in later life is the dominant influence on risk markers
both for CHD and for type 2 diabetes. Early adult BMI level may be associated
with later type 2 diabetes risk, but not with markers of CHD risk. However, it is
not possible to establish whether this association reflects the positive correlation
between BMI in early adult life and BMI in later life, or whether it reflects a more
direct association between early BMI and diabetes risk, possibly based on the
cumulative effects of BMI on insulin resistance and pancreatic beta cell function
over an extended period from early adult life. This uncertainty partly reflects the
limitations of the present cohort for investigating this issue, given the low levels of
adiposity and the low prevalence of overweight/obesity in early adult life observed
in the present cohort. However, the associations between adiposity, diabetes and
CHD in the present cohort (with a lesser burden of adiposity in early adult life
than that in subsequent cohorts) could act as a valuable reference point for
investigating the health effects of adiposity in subsequent birth cohorts, in which
adiposity in early adult life became more marked. While findings from this study
are generalizable to elderly white males, relevance to women of a similar age (who
show different patterns and trends in body composition, e.g. greater losses in
muscle mass with age), and other ethnic groups remains to be established. This
work will be carried on when cohort studies with individuals with higher levels of
adiposity in early life will become available.
Supporting Information
File S1. Supplemental material. Figure S1, Association between weight at 21 years
recalled in 1996 and weight measured during military service at age closest to 21
years (and between 20 and 22 years). Table S1, Regression coefficients showing the
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associations between BMI at 70 years (per 1 kg/m increase) and cardiovascular
and diabetes risk factors at mean age 70 years, stratified by quintiles of BMI at 21
years. Statistical appendix S1, Justification for analytic approach. Data S1, Data
underlying the findings described in the manuscript.
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